Important Safety Information

Prescription Medications Require Medical Evaluation

Certain medications require a valid prescription from a licensed healthcare provider affiliated with Remedora or LocumTele Medical Group. Before starting any prescription medication, you must have a consultation with a licensed provider who will evaluate whether the medication is appropriate for your health status and medical history. Treatment approval is not guaranteed.

Medication Risks and Side Effects

Prescription medications may involve serious health risks, side effects, and complications. Before beginning treatment, carefully review all available safety information provided by your healthcare provider and pharmacy. Discuss with your provider any concerns about potential risks, warnings, contraindications, drug interactions, or adverse effects. If you have questions about your specific medication or health condition, contact your healthcare provider directly.

Reporting Adverse Events

If you experience any adverse reactions, unexpected side effects, or complications related to your treatment, report them immediately to your healthcare provider and dispensing pharmacy. You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088 FDA MedWatch Online: www.fda.gov/medwatch

Medical Emergencies

If you believe you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately. Do not wait for a telehealth consultation.

BioLume's Role

BioLume Rx provides administrative, technology, and platform support services only. BioLume Rx does not practice medicine, provide medical advice, diagnose conditions, prescribe medications, or operate as a pharmacy. All medical evaluations, prescribing decisions, treatment recommendations, and safety determinations are made exclusively by independent licensed healthcare providers affiliated with Remedora or LocumTele Medical Group. BioLume Rx is not responsible for medical outcomes, treatment effectiveness, or adverse events.

Telehealth Limitations

Telehealth consultations have limitations compared to in-person medical evaluation. Your healthcare provider will determine whether your condition requires in-person examination or if telehealth is appropriate. Certain conditions or circumstances may require in-person care.

Trademark Ownership and Brand Disclaimers

BioLume Rx does not manufacture, own, or control any brand-name prescription medications, including but not limited to Ozempic®, Wegovy®, Mounjaro®, Zepbound®, or any other branded pharmaceutical products. These are registered trademarks of their respective manufacturers.

BioLume Rx is not affiliated with, endorsed by, or sponsored by any pharmaceutical manufacturer, including Novo Nordisk A/S, Eli Lilly and Company, or any other drug company. BioLume Rx does not claim ownership of any brand-name or FDA-approved medications referenced on this website or platform.

References to brand-name medications on the BioLume Rx platform are for informational purposes only and do not indicate that BioLume Rx manufactures, sells, or controls those medications. Any medications provided through BioLume Rx are sourced from licensed pharmacies and compounding facilities and are prescribed solely at the discretion of LocumTele Pharmacy Group with a licensed healthcare provider.

Important Safety Information regarding Compounded Semaglutide

Before Starting Semaglutide:

Tell your healthcare provider about your complete medical history, including any history of:
Kidney, liver, or pancreas problems
Thyroid disease or thyroid cancer
Gallstones or gallbladder disease
Diabetic retinopathy (if you have type II diabetes)
Severe gastrointestinal disease
Depression, behavior changes, or suicidal thoughts
Avoid alcohol while taking this medication
Do not take this medication if pregnant, trying to become pregnant, or breastfeeding. Semaglutide may cause fetal harm. If you plan to become pregnant, stop this medication at least 2 months before trying to conceive.
Use adequate contraception while taking this medication
Diabetes medications may need adjustment. If you take insulin or other diabetes medications, discuss this with your prescribing doctor before starting semaglutide, as your doses may need to be lowered to reduce the risk of low blood sugar.

Drug Interactions

Compounded semaglutide can interact with alcohol and certain prescription and non-prescription medications. The risk of low blood sugar is increased when combined with insulin or insulin secretagogues (such as Glipizide, glimepiride, or glyburide). Discuss any potential medication adjustments with your healthcare provider.

Semaglutide delays stomach emptying and may affect how your body absorbs oral medications. If you take thyroid medication (such as levothyroxine), discuss the timing of your doses with your doctor, you may need to adjust when you take it.

If you take medications with narrow therapeutic windows (such as warfarin), your doctor should monitor drug levels closely while you are on semaglutide.

Please review the complete list of side effects, warnings, interactions, and additional information provided with your pharmacy's packaging.

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to semaglutide, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Additional Important Notes

Never share semaglutide with other people. This medication is prescribed for your specific health condition.
Your healthcare provider is responsible for determining whether semaglutide is medically appropriate for your condition and for monitoring your progress.
BioLume Rx facilitates access to semaglutide through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by your licensed healthcare provider.

Black Box Warning: Thyroid Risk

GLP-1 medications are contraindicated (not safe for) individuals with:

A personal history of medullary thyroid carcinoma (thyroid cancer)
A family history of medullary thyroid carcinoma
Multiple endocrine neoplasia syndrome type 2 (MEN 2)

In animal studies, GLP-1s caused thyroid tumors, including thyroid cancer. It is not yet known whether they will cause thyroid tumors or cancer in humans. Do not take tirzepatide if you have ever had thyroid cancer. Notify your doctor immediately if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Safety Information regarding Tirzepatide

Before Starting Tirzepatide:

Tell your healthcare provider about your complete medical history, including any history of:
Kidney, liver, or pancreas problems
Thyroid disease or thyroid cancer
Gallstones or gallbladder disease
Diabetic retinopathy (if you have type II diabetes)
Severe gastrointestinal disease
Depression, behavior changes, or suicidal thoughts
Avoid alcohol while taking this medication
Do not take this medication if pregnant, trying to become pregnant, or breastfeeding. Tirzepatide may cause fetal harm. If you plan to become pregnant, stop this medication at least 2 months before trying to conceive.
Use adequate contraception while taking this medication. Tirzepatide may reduce the effectiveness of birth control pills. Discuss alternative contraception methods with your doctor and use backup contraception for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.
Diabetes medications may need adjustment. If you take insulin or other diabetes medications, discuss this with your prescribing doctor before starting tirzepatide, as your doses may need to be lowered to reduce the risk of low blood sugar.

Common Side Effects

The most frequently reported side effects of compounded tirzepatide include:

Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain or indigestion
Injection site reactions
Fatigue
Heartburn or belching
Hair loss
Allergic reactions

These side effects are not exhaustive. If you experience any persistent or bothersome side effects, discuss them with your healthcare provider for appropriate management and possible dose adjustment.

Drug Interactions

Compounded tirzepatide can interact with alcohol and certain prescription and non-prescription medications. The risk of low blood sugar is increased when combined with insulin or insulin secretagogues (such as Glipizide, glimepiride, or glyburide). Discuss any potential medication adjustments with your healthcare provider.

Tirzepatide delays stomach emptying and may affect how your body absorbs oral medications. If you take thyroid medication (such as levothyroxine), discuss the timing of your doses with your doctor, you may need to adjust when you take it.

If you take medications with narrow therapeutic windows (such as warfarin), your doctor should monitor drug levels closely while you are on tirzepatide.

Please review the complete list of side effects, warnings, interactions, and additional information provided with your pharmacy's packaging.

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to tirzepatide, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Additional Important Notes

Never share tirzepatide with other people**.** This medication is prescribed for your specific health condition.
Your healthcare provider is responsible for determining whether tirzepatide is medically appropriate for your condition and for monitoring your progress.
BioLume Rx facilitates access to tirzepatide through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Safety Information regarding Finasteride

Finasteride may affect your prostate-specific antigen (PSA) levels, which are used in prostate cancer screening. Inform your healthcare provider that you are taking finasteride before any prostate cancer screening or PSA testing. Your provider will interpret your results appropriately.

Important: Some studies suggest finasteride may increase the risk of high-grade prostate cancer in some men. Discuss this risk with your provider before starting treatment. Your provider can help you weigh the benefits and risks based on your individual health profile and family history.

Drug Interactions

Finasteride is not known to have major interactions with most medications. However, always inform your healthcare provider about:

Any prescription medications you are taking
Over-the-counter medications or supplements
Any hormonal therapies or prostate medications

Pregnancy, Breastfeeding, and Women's Use

Finasteride is not approved for use in women. Women who are pregnant or may become pregnant should never use or handle finasteride. The medication can be absorbed through the skin and may cause serious birth defects, particularly in a developing male fetus. Tablets should never be crushed or broken.

Storage and Safe Handling

Store finasteride at room temperature, away from moisture and heat
Keep tablets in their original, unopened packaging until use
Do not use expired medication
Keep finasteride out of reach of children and women of childbearing age
Do not crush, break, or split tablets

Reporting Side Effects and Concerns

If you experience any adverse reactions or unexpected side effects related to finasteride, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

BioLume Rx facilitates access through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Safety Information regarding GHK-Cu Foam

What You Need to Know Before Starting

GHK-Cu Foam is a compounded prescription therapy prepared by licensed U.S. compounding pharmacies. It is an experimental wellness treatment intended to support scalp health and tissue vitality. It is not FDA-approved for the treatment, prevention, or cure of any medical condition, including hair loss disorders such as androgenetic alopecia.

Your healthcare provider must evaluate whether GHK-Cu is appropriate for your health status and medical history before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives.

Who Should Not Use GHK-Cu Foam

Do not use GHK-Cu Foam if you:

Are pregnant or planning to become pregnant—due to limited safety data, GHK-Cu should not be used during pregnancy
Are breastfeeding
Have a known allergy to GHK-Cu, copper-containing compounds, or topical peptide formulations
Have a personal history of cancer or a diagnosis of cancer within the past five years (unless cleared by a specialist)
Have a family history of cancer or currently have an active cancer diagnosis

Because copper peptides may influence cell growth and tissue remodeling pathways, individuals with cancer or a cancer history require specialized medical clearance before using GHK-Cu.

Use with Caution: Medical Conditions Requiring Provider Review

Certain conditions warrant careful provider evaluation before starting GHK-Cu Foam. Tell your healthcare provider if you have:

Autoimmune conditions affecting the scalp (such as lupus or alopecia areata)—Although GHK-Cu is generally anti-inflammatory, autoimmune-driven scalp conditions require close supervision
Active scalp infections (fungal infections, severe seborrheic dermatitis)—resolve these before starting therapy
Copper metabolism disorders (such as Wilson's Disease)—avoid GHK-Cu or use only under specialist guidance
Hormone-sensitive conditions or current hormone replacement therapy—discuss timing and potential interactions with your provider

Common Side Effects

The most frequently reported side effects of GHK-Cu Foam include:

Localized redness, dryness, or mild itching at the application site (typically transient)
Mild scalp flaking or sensitivity, especially during the initial adjustment phase
Mild scalp irritation with repeated application

These side effects are not exhaustive. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend adjusting application frequency or discontinuing use.

Serious Side Effects: Stop Use and Seek Care

Stop using GHK-Cu Foam immediately and contact your healthcare provider if you experience:

Persistent or worsening scalp inflammation
Signs of allergic reaction (rash beyond the application site, swelling, difficulty breathing)
Unusual systemic symptoms

If you experience difficulty breathing, chest pain, severe swelling, or any other signs of a medical emergency, call 911 or go to the nearest emergency room immediately.

Concurrent Topical Treatments

If you are using other topical treatments on your scalp or face such as retinoids, corticosteroids, minoxidil, or other active peptide formulations, inform your provider. Layering multiple bioactive topical agents may increase irritation risk. Your provider may recommend applying products at different times of day to minimize irritation.

Reporting Side Effects and Concerns

If you experience any unexpected side effects or complications related to GHK-Cu Foam, report them to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Additional Important Notes

GHK-Cu Foam is prescribed for your specific health condition. Never share it with other people.
Your healthcare provider is responsible for determining whether GHK-Cu is medically appropriate for your condition and for monitoring your progress.
BioLume Rx facilitates access to GHK-Cu through partner compounding pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by your licensed healthcare provider.
This is experimental therapy. Clinical data on long-term use is limited. Your provider will discuss what to expect and how long you should use this treatment.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Safety Information regarding Glutathione Injections

What You Need to Know Before Starting

Glutathione injections are compounded prescription therapies administered intravenously or intramuscularly. Glutathione is an antioxidant naturally produced by your body; injectable glutathione is prescribed off-label as a wellness or aesthetic treatment. It is not FDA-approved for any specific medical condition.

Your healthcare provider must evaluate whether glutathione injections are appropriate for your health status and medical history before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives.

Who Should Not Use Glutathione Injections

Do not use glutathione injections if you:

Have a known allergy to glutathione or any injection components
Have a personal history of cancer or a diagnosis of cancer within the past five years (unless specifically approved by an oncologist)
Are pregnant or planning to become pregnant—due to limited safety data, glutathione should not be used during pregnancy
Are breastfeeding
Have a known history of sulfur allergies or severe sulfur sensitivity

Use with Caution: Medical Conditions Requiring Provider Review

Tell your healthcare provider if you have:

Asthma or reactive airway disease—use glutathione with caution and discuss potential respiratory considerations
Liver disease or impaired liver function—glutathione is metabolized by the liver; discuss timing and frequency with your provider
Kidney disease or impaired kidney function—discuss dosing and monitoring
History of severe allergic reactions—discuss your reaction history with your provider before starting
Autoimmune conditions—glutathione may affect immune function; discuss with your provider

Common Side Effects

The most frequently reported side effects of glutathione injections include:

Mild redness, soreness, or swelling at the injection site
Mild headache
Temporary fatigue or dizziness (typically resolves within hours)
Flushing or feeling of warmth
Nausea or mild stomach discomfort (rare)

These side effects are typically mild and short-lived, especially when injections are administered slowly. Rotating injection sites can help minimize local irritation. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend adjusting injection frequency or discontinuing use.

Serious Side Effects: Stop Use and Seek Care

Stop using glutathione injections immediately and contact your healthcare provider if you experience:

Allergic reaction: rash, itching, swelling of the face, lips, tongue, or throat
Difficulty breathing or shortness of breath
Chest tightness or chest pain
Unusual weakness, numbness, or tingling in extremities
Joint pain or severe muscle cramps
Anaphylactic reaction: severe swelling, difficulty breathing, or loss of consciousness (rare but serious)

If you experience difficulty breathing, chest pain, severe swelling, or any other signs of a medical emergency, call 911 or go to the nearest emergency room immediately.

Important Information About Allergies and Sensitivities

Glutathione is derived from amino acids and contains sulfur compounds. If you have a documented sulfur allergy or a history of severe sulfur sensitivity, discuss this with your provider before starting glutathione injections. While true sulfur allergies are uncommon, cross-reactivity is possible.

Rare cases of anaphylactic reactions have been reported with IV or intramuscular glutathione, typically in individuals with pre-existing sensitivities or allergies. Your provider will assess your allergy history before prescribing.

Drug Interactions

No major drug interactions are well-established for glutathione injections, but inform your healthcare provider about all medications and supplements you are taking, including:

Chemotherapy agents or cancer medications
Medications that affect liver metabolism
High-dose antioxidant supplements (vitamin C, vitamin E, selenium)
Diabetes medications
Blood thinners

Your provider can assess whether glutathione is appropriate for your current medication regimen and whether any adjustments are needed.

Pregnancy, Breastfeeding, and Women's Use

Glutathione injections are not recommended during pregnancy or while breastfeeding due to limited safety data. If you are pregnant, planning to become pregnant, or currently breastfeeding, discuss this with your healthcare provider before starting treatment.

Storage and Safe Handling

Store glutathione vials in the refrigerator at 2–8°C (36–46°F)
Do not freeze
Keep vials sealed and protected from direct light
Use within the prescribed time frame and follow proper injection technique
Keep out of reach of children
Do not use expired product

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to glutathione injections, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Information regarding Methylene blue

What You Need to Know Before Starting

Methylene blue is a compounded prescription therapy administered intravenously or intramuscularly. It is prescribed off-label as a cognitive-support or wellness treatment. Methylene blue is not FDA-approved for any specific medical condition and carries significant drug interaction risks that require careful provider evaluation.

Your healthcare provider must evaluate whether methylene blue is appropriate for your health status and current medications before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives.

Critical Drug Interaction: Serotonin Syndrome Risk

BLACK BOX WARNING: Methylene blue can cause serious or fatal serotonin syndrome when used with certain antidepressants and psychiatric medications.

Methylene blue inhibits an enzyme called monoamine oxidase A (MAO-A), which normally breaks down serotonin in your brain. When you take methylene blue alongside medications that increase serotonin levels—such as SSRIs, SNRIs, MAOIs, tricyclic antidepressants, or other serotonergic drugs—the combination can cause dangerous serotonin buildup.

Do not use methylene blue if you are taking any of these medications:

SSRIs (sertraline, fluoxetine, paroxetine, citalopram, escitalopram, venlafaxine)
SNRIs (venlafaxine, duloxetine, desvenlafaxine)
MAOIs (phenelzine, tranylcypromine, isocarboxazid)
Tricyclic antidepressants (amitriptyline, nortriptyline, doxepin)
ADHD stimulants (methylphenidate, amphetamine)
Other serotonergic medications

If you take any of these medications and your provider believes methylene blue is necessary in an emergency situation, your provider must discontinue your serotonergic medication at least 2 weeks before starting methylene blue and monitor you closely for serotonin syndrome symptoms.

Symptoms of Serotonin Syndrome: Seek Immediate Care

Stop using methylene blue and seek emergency care immediately if you experience:

Agitation, restlessness, or anxiety
Confusion or disorientation
Rapid or abnormal heart rate
High blood pressure
Dilated pupils
Loss of muscle coordination, muscle twitching, or involuntary jerking
Muscle rigidity or stiffness
Heavy sweating or fever
Diarrhea, nausea, or vomiting
Severe cases: high fever, seizures, or loss of consciousness

If you experience difficulty breathing, severe fever, seizures, or loss of consciousness, call 911 or go to the nearest emergency room immediately.

Who Should Not Use Methylene Blue

Do not use methylene blue if you:

Have G6PD deficiency (a genetic blood disorder that increases risk of hemolytic anemia with methylene blue)
Are taking SSRIs, SNRIs, MAOIs, or ADHD stimulants (see Critical Drug Interaction section above)
Have a known allergy to methylene blue or any injection components
Are pregnant or planning to become pregnant
Are breastfeeding

Common Side Effects

The most frequently reported side effects of methylene blue include:

Headache
Blue or green discoloration of urine and other body secretions (harmless and temporary)
Diarrhea or nausea
Low potassium levels (hypokalemia)
Low magnesium levels (hypomagnesemia)
Muscle twitching or sudden involuntary muscle jerks (myoclonus)
Mild seizure-like phenomena

These side effects are typically mild and resolve after discontinuation. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend dose adjustment or discontinuing use.

Serious Side Effects: Stop Use and Seek Care

Stop using methylene blue immediately and contact your healthcare provider if you experience:

Signs of hemolytic anemia (severe fatigue, yellowing of eyes or skin, dark urine, shortness of breath)—especially if you have G6PD deficiency
Severe or persistent diarrhea
Significant changes in heart rate or blood pressure
Difficulty breathing or respiratory symptoms
Vision problems or eye pain

Important Information About G6PD Deficiency

Methylene blue carries a risk of hemolytic anemia (breakdown of red blood cells), particularly in individuals with G6PD deficiency, a genetic blood disorder that affects how your body processes certain medications. If you have a family history of G6PD deficiency, hemolytic anemia, or sickle cell disease, discuss this with your provider before starting methylene blue. Genetic testing may be recommended.

Drug Interactions and Medication Disclosure

Beyond the critical serotonin-syndrome risk listed above, inform your healthcare provider about all medications and supplements you are taking, including:

Any other psychiatric or mood medications
Blood thinners or anticoagulants
Medications that affect liver metabolism
High-dose antioxidant supplements

Methylene blue may interfere with certain laboratory tests and in-vivo monitoring devices used during medical procedures. Inform any healthcare providers or laboratories that you are taking methylene blue before undergoing blood work or medical testing.

Storage and Safe Handling

Store methylene blue in a cool, dry place away from direct sunlight
Do not freeze
Keep out of reach of children
Do not use expired product
Methylene blue is photosensitizing; avoid excessive light exposure

Pregnancy, Breastfeeding, and Women's Use

Methylene blue is not recommended during pregnancy or while breastfeeding due to limited safety data. If you are pregnant, planning to become pregnant, or currently breastfeeding, do not start methylene blue without explicit approval from your healthcare provider.

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or symptoms of serotonin syndrome related to methylene blue, report them immediately to:

Your healthcare provider
Your dispensing pharmacy
Emergency services (911) if symptoms are severe

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Information regarding Minoxidil

Methylene blue is prescribed for your specific health goals. Never share injections with other people.

Your healthcare provider is responsible for determining whether methylene blue is medically appropriate for your condition and for monitoring your progress, including regular assessment for serotonin syndrome symptoms.
This is an off-label therapy. Clinical evidence supporting its use for cognitive support or wellness is limited. Your provider will discuss realistic expectations and appropriate duration of use.

Minoxidil: Safety Information and Important Warnings

What You Need to Know Before Starting

Minoxidil is FDA-approved for topical use in treating male-pattern hair loss (androgenetic alopecia). BioLume's compounded oral minoxidil formulations are not FDA-approved and are prescribed off-label as hair-restoration treatments. By choosing compounded oral minoxidil, you acknowledge this regulatory difference and accept the medication under state pharmacy board oversight rather than federal FDA review.

Your healthcare provider must evaluate whether oral minoxidil is appropriate for your health status and medical history before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives, including topical options.

Who Should Not Use Minoxidil

Do not use minoxidil if you:

Have a known allergy to minoxidil or any injection components
Are pregnant or planning to become pregnant—due to limited safety data with oral minoxidil, it is not recommended during pregnancy
Are breastfeeding
Have pheochromocytoma (a rare adrenal tumor)—minoxidil's blood-vessel-dilating effects make it unsafe in this condition
Have uncontrolled high blood pressure

Use with Caution: Medical Conditions Requiring Provider Review

Tell your healthcare provider if you have:

History of heart failure or recent cardiovascular events (heart attack, stroke, arrhythmia)—minoxidil affects blood pressure and heart function
Uncontrolled or severe hypertension (high blood pressure)—minoxidil is a vasodilator and can lower blood pressure further
Kidney or liver disease—discuss dosing and monitoring with your provider
Fluid retention or edema (swelling in feet, legs, or hands)—minoxidil can worsen fluid retention
Thyroid disease or thyroid medication use—discuss potential interactions with your provider
Diabetes or blood-sugar control issues—minoxidil may affect glucose levels

Critical Warnings: Seek Immediate Care

Stop using minoxidil and seek in-person emergency care immediately if you experience:

Chest pain or pressure
Severe shortness of breath or difficulty breathing
Fainting or severe dizziness
Rapid or irregular heartbeat (palpitations)
Severe headache that does not resolve with rest
Severe swelling of the face, lips, tongue, or throat
Signs of a severe allergic reaction: rash, itching, or difficulty breathing

If you experience any of these symptoms, call 911 or go to the nearest emergency room immediately.

Common Side Effects

The most frequently reported side effects of oral minoxidil include:

Lightheadedness or mild dizziness
Fluid retention (swelling in feet, legs, or hands)
Mild heart palpitations (feeling your heartbeat)
Increased facial or body hair growth (in women)
Mild headache

These side effects are typically mild and often improve with continued use or dose adjustment. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend dose reduction or discontinuing use.

Serious but Uncommon Side Effects

Significant dizziness or hypotension (low blood pressure)
Breast lumps or nipple discharge
Severe allergic reaction (rash, swelling, difficulty breathing)

If you experience any of these, contact your provider immediately.

Important Information About Blood Pressure and Heart Function

Minoxidil is a potent vasodilator, meaning it relaxes blood vessels and lowers blood pressure. If you have a history of high blood pressure, heart disease, or heart failure, your provider will need to monitor you closely while you take minoxidil. You may need periodic blood-pressure checks or heart monitoring, depending on your health history.

Do not use minoxidil if your blood pressure is uncontrolled. Discuss your blood pressure goals and monitoring plan with your provider before starting treatment.

Drug Interactions

Minoxidil can interact with blood-pressure-lowering medications, potentially causing additive blood-pressure effects. Inform your healthcare provider about all medications and supplements you are taking, including:

Antihypertensive medications (blood-pressure medications)
Diuretics (water pills)
NSAIDs (like ibuprofen or naproxen)
Stimulants or decongestants
Herbal supplements that affect blood pressure

Your provider will determine whether dose adjustments are necessary and may recommend periodic lab monitoring (potassium levels, renal function, or heart function) depending on your medications and health history.

Pregnancy, Breastfeeding, and Women's Use

Minoxidil is not recommended during pregnancy or while breastfeeding due to limited safety data, particularly with oral formulations. If you are pregnant, planning to become pregnant, or currently breastfeeding, do not start minoxidil without explicit approval from your healthcare provider.

Storage and Safe Handling

Store minoxidil at room temperature, away from moisture and heat
Keep out of reach of children
Do not use expired medication
Keep in original packaging

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to minoxidil, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Additional Important Notes

Minoxidil is prescribed for your specific health condition. Never share it with other people.
Your healthcare provider is responsible for determining whether minoxidil is medically appropriate for your condition and for monitoring your progress, including periodic blood-pressure checks or heart monitoring if clinically indicated.
Compounded oral minoxidil is an off-label therapy. Clinical evidence supporting its use for hair restoration is limited. Your provider will discuss realistic expectations and appropriate duration of use.
BioLume Rx facilitates access through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Information Regarding NAD+ (Nicotinamide Adenine Dinucleotide)

What You Need to Know Before Starting

NAD+ is a compounded prescription therapy available in multiple formulations: intravenous injection, nasal spray, topical face cream, and transdermal patch. NAD+ is prescribed off-label as a wellness or cellular-support treatment. It is not FDA-approved for any specific medical condition.

Your healthcare provider must evaluate whether NAD+ is appropriate for your health status and medical history before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives.

Critical Warnings: Seek Immediate Care

Stop using NAD+ and seek in-person emergency care immediately if you experience:

Difficulty breathing or shortness of breath
Chest pain or pressure
Severe swelling of the face, lips, tongue, or throat
Signs of a severe allergic reaction: rash, itching, or difficulty breathing
Fainting or severe dizziness (especially after injection)
Severe or persistent fatigue accompanied by fever or flu-like symptoms
Rapid or irregular heartbeat with flushing or sweating

If you experience any of these symptoms, call 911 or go to the nearest emergency room immediately.

Common Side Effects by Formulation

NAD+ Injection (IV or Intramuscular):

Redness, tenderness, or soreness at the injection site
Mild flushing or feeling of warmth
Lightheadedness or mild dizziness
Temporary fatigue or tiredness
Mild nausea

NAD+ Nasal Spray:

Nasal dryness or irritation
Sneezing or transient burning sensation in the nose
Mild headache
Mild dizziness

NAD+ Topical Face Cream:

Skin sensitivity or mild irritation at the application site
Temporary redness or tingling
Dryness or irritation, especially with overuse

NAD+ Transdermal Patch:

Skin irritation under or around the patch
Itching or redness at the application site

These side effects are generally mild and short-lived. Rotating injection or application sites and following your provider's guidance can help reduce irritation risk. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend adjusting frequency or discontinuing use.

Important Safety Information

Before Starting NAD+:

Tell your healthcare provider about your complete medical history, including:
Autoimmune conditions
Cardiovascular disease or history of heart problems
Metabolic disorders (diabetes, thyroid disease)
Liver or kidney disease
Any known allergies to NAD+ or formulation components
Do not exceed the dose prescribed by your provider. NAD+ dosing must be individualized based on your health status.
Injection technique matters: NAD+ injections must be administered subcutaneously (under the skin) using proper technique. Improper administration may increase irritation or localized reaction risk.
Nasal spray formulations: Use carefully to avoid irritation or overuse. Follow your provider's instructions on frequency and application.

Serious but Uncommon Side Effects

Dizziness or fainting (especially post-injection)
Persistent fatigue or flu-like symptoms
Flushing with rapid or irregular heartbeat
Allergic reaction: rash, swelling, or difficulty breathing (rare)

If you experience any of these, stop use immediately and contact your provider.

Important Information About Autoimmune, Cardiovascular, and Metabolic Conditions

NAD+ affects mitochondrial function and cellular energy metabolism. If you have autoimmune conditions, cardiovascular disease, or metabolic disorders (such as diabetes or thyroid disease), your provider will need to monitor you more closely while you use NAD+. These conditions may warrant periodic blood work or clinical assessment to ensure NAD+ is safe and appropriate for your situation.

Drug Interactions

No widely reported systemic drug interactions are known for topical NAD+ formulations due to minimal systemic absorption. However, inform your healthcare provider about all medications and supplements you are taking, especially:

Insulin or diabetes medications
Metformin or other metabolic medications
Corticosteroids
Any other bioactive supplements or high-dose antioxidants

Your provider can assess whether NAD+ is appropriate for your current medication regimen.

Pregnancy, Breastfeeding, and Women's Use

NAD+ products are not recommended during pregnancy or while breastfeeding due to limited safety data in these populations. If you are pregnant, planning to become pregnant, or currently breastfeeding, discuss alternative options with your healthcare provider before starting NAD+.

Storage and Safe Handling

NAD+ Injection:

Store in the refrigerator at 2–8°C (36–46°F)
Do not freeze
Protect from light
Use within the prescribed time frame

NAD+ Nasal Spray:

Store at room temperature
Keep the cap tightly closed
Avoid contamination of the nozzle
Do not share with others

NAD+ Topical Face Cream:

Store in a cool, dry place, away from direct sunlight and heat

NAD+ Transdermal Patch:

Store sealed in original packaging until use
Keep in a dry environment

All Formulations:

Keep out of reach of children
Do not use any product past its expiration date

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to NAD+, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Additional Important Notes

NAD+ is prescribed for your specific health goals. Never share your formulation with other people.
Your healthcare provider is responsible for determining whether NAD+ is medically appropriate for your condition and for monitoring your progress, especially if you have autoimmune, cardiovascular, or metabolic conditions.
NAD+ is an off-label therapy. Clinical evidence supporting its use for wellness or cellular support is limited and evolving. Your provider will discuss realistic expectations and appropriate duration of use.
BioLume Rx facilitates access through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Information regarding Sermorelin

What You Need to Know Before Starting

Sermorelin is a compounded prescription therapy administered as an injection or orally-disintegrating tablet (ODT). Sermorelin is a growth-hormone-releasing hormone analog prescribed off-label as a wellness or anti-aging treatment. It is not FDA-approved for any specific medical condition.

Your healthcare provider must evaluate whether sermorelin is appropriate for your health status and medical history before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives.

Critical Warnings: Seek Immediate Care

Stop using sermorelin and seek in-person emergency care immediately if you experience:

Severe allergic reaction: swelling of face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash or itching
Difficulty breathing or shortness of breath
Chest pain or pressure
Severe dizziness or fainting
Rapid or irregular heartbeat

If you experience any of these symptoms, call 911 or go to the nearest emergency room immediately.

Who Should Not Use Sermorelin

Do not use sermorelin if you:

Have a known allergy to sermorelin or any injection/tablet components
Are pregnant or planning to become pregnant—due to limited safety data, sermorelin should not be used during pregnancy
Are breastfeeding
Have a personal history of cancer or a diagnosis of cancer that is not in remission
Have a family history of cancer (discuss with your provider before starting)

Important Safety Information regarding Sermorelin

Before Starting Sermorelin:

Tell your healthcare provider about your complete medical history, including:
History of cancer or current cancer diagnosis
Metabolic or endocrine conditions (diabetes, thyroid disease)
Liver or kidney disease
Cardiovascular disease or heart problems
Any known allergies to sermorelin or its components
Regular monitoring is important. Sermorelin affects hormone levels and metabolism. Your provider will monitor you for changes in your hormone levels and overall health status.

Common Side Effects

The most frequently reported side effects of sermorelin include:

Sermorelin Injection:

Pain, redness, or swelling at the injection site
Mild fatigue or tiredness
Mild dizziness or lightheadedness

Sermorelin ODT (Oral Tablet):

Temporary changes in taste or dry mouth after taking the tablet
Mild fatigue or tiredness
Mild dizziness or lightheadedness

These side effects are typically mild and often improve with continued use. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend dose adjustment or discontinuing use.

Uncommon but Possible Side Effects

Itching or rash
Trouble swallowing
Flushing or feeling of warmth
Headache
Sleepiness or unusual fatigue
Hyperactivity or restlessness

Most of these effects are temporary and resolve with continued use or dose adjustment. If any symptom becomes bothersome or does not go away, contact your healthcare provider.

Important Information About Hormone Levels and Metabolism

Sermorelin stimulates the release of growth hormone, which affects your body's metabolism, energy, and cellular function. Because sermorelin alters hormone levels, your provider may recommend periodic monitoring or lab work to track your response to treatment and ensure the therapy is safe and appropriate for your situation. If you have a history of metabolic or endocrine conditions (such as diabetes or thyroid disease), your provider will need to monitor you more closely.

Drug Interactions

Inform your healthcare provider about all medications and supplements you are taking, especially:

Glucocorticoids (such as prednisone)—may reduce the effectiveness of sermorelin's growth-hormone-stimulating effects
Thyroid medications (such as levothyroxine)—may affect hormonal balance or interfere with monitoring
Any other hormone-related medications
High-dose antioxidant supplements or other bioactive agents

Your provider can assess whether sermorelin is appropriate for your current medication regimen and whether any adjustments or monitoring is needed.

Pregnancy, Breastfeeding, and Women's Use

Sermorelin is not recommended during pregnancy or while breastfeeding due to limited safety data in these populations. If you are pregnant, planning to become pregnant, or currently breastfeeding, do not start sermorelin without explicit approval from your healthcare provider.

Use effective contraception while taking sermorelin unless otherwise directed by your provider.

Storage and Safe Handling

Sermorelin Injection:

Store in the refrigerator at 2–8°C (36–46°F)
Do not freeze
Protect from light
Use within the prescribed time frame

Sermorelin ODT (Oral Tablet):

Store at room temperature, in a dry place away from heat, moisture, and direct sunlight

All Formulations:

Keep out of reach of children
Do not use any product past its expiration date printed on the packaging

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to sermorelin, report them immediately to:

Your healthcare provider
Your dispensing pharmacy

You may also report suspected adverse events directly to the FDA:

FDA MedWatch Hotline: 1-800-FDA-1088
FDA MedWatch Online: www.fda.gov/medwatch

Additional Important Notes

Sermorelin is prescribed for your specific health goals. Never share your prescription with other people.
Your healthcare provider is responsible for determining whether sermorelin is medically appropriate for your condition and for monitoring your progress, including hormone levels and metabolic response.
Sermorelin is an off-label therapy. Clinical evidence supporting its use for anti-aging or wellness is limited and evolving. Your provider will discuss realistic expectations and appropriate duration of use.
BioLume Rx facilitates access through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Information regarding Vardenafil and Tadalafil

What You Need to Know Before Starting

Vardenafil and tadalafil are compounded prescription therapies prescribed off-label for erectile dysfunction. Both are phosphodiesterase-5 (PDE-5) inhibitors. While vardenafil and tadalafil are FDA-approved when manufactured by brand-name companies (Levitra and Cialis, respectively), compounded formulations are not FDA-approved. By choosing compounded versions, you're accepting the medication under state pharmacy board oversight rather than federal FDA review.

Your healthcare provider must evaluate whether vardenafil or tadalafil is right for your health status and medical history before prescribing. You have the right to ask why they're recommending this therapy and to discuss alternatives.

Critical Drug Interaction: Nitrates

BLACK BOX WARNING: Do not use vardenafil or tadalafil if you are taking any nitrate medication. This combination can cause a dangerous and potentially fatal drop in blood pressure.

Nitrate medications include nitroglycerin (tablets, patches, spray), isosorbide dinitrate or mononitrate, and any other nitrate-based chest pain medication.

If you take nitrates for heart disease or chest pain, you cannot safely use vardenafil or tadalafil. Talk to your provider about alternative ED treatments.

Who Should Not Use Vardenafil or Tadalafil

Do not use if you:

Are taking any nitrate medications
Are taking other ED medications (sildenafil, avanafil)—combining PDE-5 inhibitors increases serious side-effect risk
Have severe, uncontrolled high or low blood pressure
Have had a heart attack, stroke, or severe heart arrhythmia within the past 6 months
Have severe liver or kidney disease
Have a known allergy to vardenafil, tadalafil, or any formulation components

Important Safety Information Before Starting

Tell your healthcare provider about your complete medical history, especially:

Heart disease, high blood pressure, or history of heart attack or stroke
Liver or kidney disease
Vision or hearing loss
Bleeding disorders or use of blood thinners
Any previous prolonged erections (priapism)

Your provider will assess your cardiovascular health before prescribing and may recommend monitoring during treatment, particularly if you have pre-existing heart conditions.

Common Side Effects

The most frequently reported side effects include:

Headache
Facial flushing (redness or warmth)
Nasal congestion
Indigestion or upset stomach
Back pain (especially with tadalafil)
Muscle aches
Mild vision changes (blurred vision or blue-tinted color vision)

These are typically mild and often improve with continued use or lower doses. If persistent side effects bother you, contact your provider; they may recommend dose adjustment or discontinuing use.

Serious But Uncommon Side Effects: Stop Use and Seek Care

Stop using immediately and contact your healthcare provider if you experience:

Priapism: Prolonged erection lasting more than 4 hours without sexual stimulation—this is a medical emergency
Sudden hearing loss or ringing in ears
Sudden vision loss or significant vision changes
Chest pain or pressure (especially during or after sexual activity)
Severe dizziness or fainting
Shortness of breath or difficulty breathing
Rapid or irregular heartbeat

If you experience chest pain, severe dizziness, fainting, priapism, or difficulty breathing, call 911 or go to the nearest emergency room immediately.

Priapism: A Medical Emergency

Priapism is a prolonged, painful erection lasting more than 4 hours that happens without sexual activity. While rare, priapism can cause permanent erectile dysfunction if not treated promptly. If your erection lasts longer than 4 hours, stop sexual activity and seek immediate emergency care. Do not wait.

Vision and Hearing Loss

Rare but documented cases of sudden vision loss (non-arteritic anterior ischemic optic neuropathy, or NAION) and sudden hearing loss have been reported with PDE-5 inhibitors. If you experience sudden vision changes, difficulty seeing colors, or sudden hearing loss or ringing in your ears, stop the medication and seek care immediately.

Cardiovascular Considerations

Vardenafil and tadalafil dilate blood vessels and lower blood pressure. Sexual activity increases the workload on your heart. Together, that's a real consideration if you have cardiovascular disease, heart failure, or a history of heart attack or stroke. Your provider may recommend cardiovascular assessment before prescribing.

Do not use these medications if you have uncontrolled high or low blood pressure.

Drug Interactions

Inform your provider about all medications and supplements you're taking, especially:

Nitrate medications (see above)
Alpha-blockers (doxazosin, terazosin, prazosin)—may cause excessive blood-pressure lowering
Blood-pressure medications (ACE inhibitors, beta-blockers, calcium-channel blockers, diuretics)
Protease inhibitors or ritonavir (HIV medications)
Ketoconazole or itraconazole (antifungal medications)
Erythromycin or clarithromycin (antibiotics)
Grapefruit or grapefruit juice—may increase side-effect risk
Other ED medications—do not combine

Your provider can determine whether adjustments or monitoring are needed based on your current regimen.

Pregnancy, Breastfeeding, and Women's Use

Vardenafil and tadalafil are not intended for use in women and are not FDA-approved for female sexual dysfunction. These medications are for men only.

Storage and Safe Handling

Store at room temperature, away from moisture and heat
Protect from direct light
Keep out of reach of children
Do not use past the expiration date

Reporting Side Effects

If you experience any adverse reactions or complications, report them to:

Your healthcare provider
Your dispensing pharmacy
FDA MedWatch: 1-800-FDA-1088 or www.fda.gov/medwatch

Monitoring Plan

To keep you safe and track effectiveness, your provider will:

Baseline Assessment: Evaluate your cardiovascular health, blood pressure, medications, and potential interactions before prescribing
Ongoing Monitoring: Check for side effects, blood-pressure changes, and new cardiovascular symptoms during follow-up visits
Symptom Monitoring: Watch for vision changes, hearing loss, or chest pain during sexual activity
Follow-Up Visits: Discuss your progress, side effects, and whether the therapy is working

Additional Important Notes

Vardenafil and tadalafil are prescribed for your specific health condition. Never share these medications with others.
Your healthcare provider is responsible for determining medical appropriateness and monitoring your progress, including cardiovascular safety.
These are off-label therapies. Clinical evidence supporting their use for ED is strong, but individual response varies. Your provider will discuss realistic expectations and appropriate duration of use.
BioLume Rx facilitates access through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.

Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Important Information regarding Zepbound® (Tirzepatide)

What You Need to Know Before Starting

Zepbound is a prescription injectable medication containing tirzepatide, a GLP-1 receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Zepbound is FDA-approved for chronic weight management in adults with obesity or overweight who have weight-related medical conditions. It is prescribed to be used alongside reduced-calorie diet and increased physical activity.

Your healthcare provider must evaluate whether Zepbound is appropriate for your health status and medical history before prescribing. You have the right to ask your provider why they're recommending this therapy and to discuss any concerns or alternatives.

Critical Warnings: Seek Immediate Care

Stop using Zepbound and seek in-person emergency care immediately if you experience:

Severe abdominal pain that does not go away, with or without vomiting—especially if you feel the pain radiating to your back (possible pancreatitis)
Difficulty breathing or shortness of breath
Severe allergic reaction: swelling of face, lips, tongue, or throat; difficulty swallowing; severe rash or itching
Chest pain or pressure
Rapid or irregular heartbeat
Signs of severe dehydration: extreme thirst, dark urine, dizziness, fainting
Vision changes or vision loss
Thoughts of suicide or severe depression or behavior changes that worry you

If you experience any of these symptoms, call 911 or go to the nearest emergency room immediately.

Who Should Not Use Zepbound

Do not use Zepbound if you:

Have a personal or family history of medullary thyroid carcinoma (MTC)
Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Have a known allergy to tirzepatide or any Zepbound components
Are pregnant or planning to become pregnant
Are breastfeeding
Have active pancreatitis or a history of pancreatitis
Have type 1 diabetes
Have diabetic ketoacidosis (DKA)

Important Safety Information

Before Starting Zepbound:

Tell your healthcare provider about your complete medical history, including:
Personal or family history of thyroid cancer or thyroid problems
History of pancreatitis or pancreatic disease
Kidney or liver disease
Vision problems or diabetic retinopathy (if you have type 2 diabetes)
History of depression, anxiety, or mental health conditions
Gallbladder disease or history of gallstones
Any allergies to tirzepatide or GLP-1 medications
Regular monitoring is important. Your provider will assess you before prescribing and may recommend periodic check-ins to monitor your weight loss progress, side effects, and overall health response to the medication.

Thyroid Tumor Risk

Zepbound may cause thyroid tumors, including thyroid cancer, in animals. It is not known if this risk applies to humans. Watch for possible symptoms and report them to your provider immediately:

Lump or swelling in the neck
Hoarseness or voice changes
Trouble swallowing
Shortness of breath
Persistent neck pain

If you have any of these symptoms, stop using Zepbound and contact your provider right away.

Common Side Effects

The most frequently reported side effects of Zepbound include:

Nausea or vomiting (often decreases over time)
Diarrhea or constipation
Stomach (abdominal) pain or indigestion
Feeling tired or fatigue
Injection-site reactions (redness, pain, swelling)
Belching or heartburn
Hair loss (temporary)
Allergic reactions (mild rash or itching)

These side effects are typically mild and often improve as your body adjusts to the medication. GI side effects may be more noticeable when you increase your dose but usually decrease over time. If you experience persistent or bothersome side effects, contact your healthcare provider; they may recommend dose adjustment, slower dose escalation, or discontinuing use.

Serious But Less Common Side Effects: Stop Use and Seek Care

Stop using Zepbound immediately and contact your healthcare provider if you experience:

Severe stomach problems: persistent severe abdominal pain, severe vomiting, inability to keep food or fluids down
Signs of pancreatitis: severe abdominal pain (with or without vomiting), pain radiating to your back
Kidney problems: significant changes in urination, swelling in feet or legs, extreme fatigue
Gallbladder problems: pain in upper abdomen, fever, yellowing of skin or eyes (jaundice), clay-colored stools
Severe allergic reaction: swelling of face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash
Serious vision changes: sudden vision loss, blurred vision, or significant changes in color vision
Signs of low blood sugar: dizziness, sweating, confusion, headache, blurred vision, shakiness, fast heartbeat (especially if taking diabetes medications)
Mental health changes: new or worsening depression, anxiety, mood changes, or thoughts of suicide

Important Health Conditions That Require Close Monitoring

Dehydration Risk: Nausea, vomiting, and diarrhea can cause loss of fluids, leading to dehydration and kidney problems. Drink plenty of fluids while taking Zepbound to reduce your risk of dehydration.

Type 2 Diabetes: If you take diabetes medications such as insulin or sulfonylureas, your risk of low blood sugar may increase when combined with Zepbound. Your provider will monitor your blood sugar and may adjust your diabetes medications. Learn to recognize and manage low blood sugar symptoms.

Vision Changes: If you have type 2 diabetes, tell your provider immediately if you experience any vision changes during treatment. Zepbound may affect your eyes or worsen existing vision problems.

Mental Health: Pay close attention to any changes in your mood, behaviors, feelings, or thoughts. Call your provider right away if you have any mental changes that are new, worse, or worry you, including thoughts of suicide or self-harm.

Drug Interactions

Inform your healthcare provider about all medications and supplements you are taking, especially:

Diabetes medications (insulin or sulfonylureas such as glipizide or glyburide)—may increase risk of low blood sugar
Blood-thinner medications (warfarin)—Zepbound may affect how your body processes these
Oral birth control pills—birth control pills may not work as well while taking Zepbound; your provider may recommend backup contraception for 4 weeks after starting Zepbound and for 4 weeks after each dose increase
Other GLP-1 medications (semaglutide, liraglutide)—do not combine with Zepbound
Thyroid medications—may need monitoring or adjustment

Your provider can determine whether Zepbound is appropriate for your current medications and whether any adjustments are needed.

Pregnancy, Breastfeeding, and Women's Use

Zepbound may harm your unborn baby and should not be used during pregnancy. If you become pregnant while taking Zepbound, stop the medication and contact your provider immediately. Zepbound is not recommended while breastfeeding because it is not known if tirzepatide passes into breast milk.

If you are of childbearing age and capable of becoming pregnant, use effective contraception while taking Zepbound unless otherwise directed by your provider.

Pregnancy Exposure Registry: If you take Zepbound during pregnancy, you may be eligible to participate in a pregnancy exposure registry that collects information about your health and your baby's health. Ask your provider about enrollment, or contact Eli Lilly at 1-800-LillyRx (1-800-545-5979) for more information.

Storage and Safe Handling

Store Zepbound pens in the refrigerator at 2–8°C (36–46°F)
Do not freeze
Protect from light
After first use, store at room temperature (below 30°C / 86°F) and use within 28 days
Keep out of reach of children
Do not use past the expiration date

Before You Start: Questions to Discuss with Your Provider

Review these questions with your healthcare provider before beginning Zepbound:

Do you have a personal or family history of thyroid cancer or MEN 2?
Do you take diabetes medications like insulin or sulfonylureas?
Do you have a history of pancreatitis, gallbladder disease, or kidney problems?
Do you have diabetic retinopathy or other vision problems?
Do you have a history of depression, anxiety, or mental health conditions?
Are you taking any other medications, supplements, or herbal products?
Are you pregnant, planning to become pregnant, or breastfeeding?

Reporting Side Effects and Concerns

If you experience any adverse reactions, unexpected side effects, or complications related to Zepbound, report them immediately to:

Your healthcare provider
Your dispensing pharmacy
FDA MedWatch: 1-800-FDA-1088 or www.fda.gov/medwatch

Additional Important Notes

Zepbound is prescribed for your specific health condition. Never share this medication with other people.
Zepbound is FDA-approved and has undergone clinical trials, but individual response varies significantly. Your provider will discuss realistic expectations for weight loss and appropriate duration of use.
Zepbound is most effective when used with reduced-calorie diet, increased physical activity, and behavioral changes. Weight loss is typically gradual.
BioLume Rx facilitates access through partner pharmacies but does not provide medical advice, prescribing, or medical supervision. All medical decisions are made by LocumTele Medical Group licensed provider group.